Fusion Pharmaceuticals Inc.: 25-NSE filed Jun 5, 2024

Form type

25-NSE

Filing date

Jun 5, 2024

Accession number

0001354457-24-000389

Filer

Fusion Pharmaceuticals Inc. (CIK 1805890)